Obicetrapib

3 trials 2 recruiting

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

2 Sponsors

13 Countries

Phase III

Phase III: 3

Sponsors using this IMP

NewAmsterdam Pharma B.V. 2 A. Menarini International Licensing S.A. 1

All trials

3 total

Obicetrapib Versus Bempedoic Acid to Treat Dyslipidemia in Patients at High to Very High Cardiovascular Risk Recruiting

2025-524265-24-00 Phase III 7 countries A. Menarini International Licensing S.A.
A Study to Evaluate the Effect of Obicetrapib and Ezetimibe Fixed-Dose Combination (FDC) or Obicetrapib on LDL-C in Participants With Type 2… Recruiting

2025-521936-12-00 Phase III 3 countries NewAmsterdam Pharma B.V.
A Placebo-Controlled Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With Atherosclerotic Cardiovascular Disease … Ended

2023-507795-51-00 Phase III 13 countries NewAmsterdam Pharma B.V.

Showing 1–3 of 3 trials

← All drugs A–Z